Report of Foreign Issuer (6-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2013

 

Commission File Number: 1-32186

 

YM BIOSCIENCES INC.

 

(Translation of registrant's name into English)

Suite 400, Building 11 5045 Orbiter Drive Mississauga, Ontario Canada L4W 4Y4

 

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  o

Form 40-F x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)   o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)   o

 

 

 

 

 

 

 

 

DOCUMENTS FILED

 

See the Exhibit Index hereto.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	YM BIOSCIENCES INC.
	By:	/s/ Leonard Vernon
		Leonard Vernon Vice President, Finance and Administration

 

Date: February 8, 2013

 

 

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit		Description
99.1		News Release Dated February 8, 2013 - GILEAD SCIENCES COMPLETES ACQUISITION OF YM BIOSCIENCES